Morphic Holding Inc logo

Morphic Holding Inc Share Price (NASDAQ: MORF)

▲

-56.99

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 15 Aug 2024

Check the interactive Morphic Holding Inc Stock chart to analyse performance

Morphic Holding Inc Key Stats

Check Morphic Holding Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$56.99
Open
$56.98
Market Capitalization
$2.9B
Today's Volume
$1.8M
Revenue TTM
$0.0
EBITDA
$-211.9M
Earnings Per Share (EPS)
$-3.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-26.69%

Global Institutional Holdings in Morphic Holding Inc

  • Name

    Holdings %

  • FMR Inc

    14.94%

  • Point72 Asset Management, L.P.

    9.33%

  • Wellington Management Company LLP

    8.01%

  • BlackRock Inc

    6.54%

  • State Street Corporation

    5.31%

  • T. Rowe Price Associates, Inc.

    5.02%

Analyst Recommendation on Morphic Holding Inc Stock

Rating
Trend

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Morphic Holding Inc(by analysts ranked 0 to 5 stars)

About Morphic Holding Inc

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Organization
Morphic Holding Inc
Employees
128
CEO
Dr. Praveen P. Tipirneni M.B.A., M.D.
Industry
Health Technology

Important FAQs about investing in MORF Stock from India :

What is Morphic Holding Inc share price today?

Morphic Holding Inc share price today is as on at the close of the market. Morphic Holding Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Morphic Holding Inc share?

Morphic Holding Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Morphic Holding Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Morphic Holding Inc Stock (MORF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Morphic Holding Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Morphic Holding Inc Shares .

What is the minimum amount required to buy Morphic Holding Inc Stock (MORF) from India?

Indian investors can start investing in Morphic Holding Inc (MORF) shares with as little as ₹88.2013 or $1 (as of September 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Morphic Holding Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025). Learn more about fractional shares .

What are the returns that Morphic Holding Inc has given to Indian investors in the last 5 years?

Morphic Holding Inc stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?